167 related articles for article (PubMed ID: 38605325)
1. HIV viral suppression and risk of viral rebound in patients on antiretroviral therapy: a two- year retrospective cohort study in Northern Tanzania.
Kahabuka MS; Woldeamanuel Y; Mbelele PM; Mpolya EA; Mpagama SG; Kessy JP; Manyazewal T
BMC Infect Dis; 2024 Apr; 24(1):390. PubMed ID: 38605325
[TBL] [Abstract][Full Text] [Related]
2. HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa.
Teasdale CA; Sogaula N; Yuengling KA; Wang C; Mutiti A; Arpadi S; Nxele M; Pepeta L; Mogashoa M; Rivadeneira ED; Abrams EJ
J Int AIDS Soc; 2018 Aug; 21(8):e25168. PubMed ID: 30094952
[TBL] [Abstract][Full Text] [Related]
3. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
Shoko C; Chikobvu D; Bessong PO
S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
[TBL] [Abstract][Full Text] [Related]
4. Viral load suppression after intensive adherence counselling among adult people living with HIV at Kiswa health centre, Kampala: a retrospective cohort study. Secondary data analysis.
Nakaye C; Mukiza N; Mawanda D; Kataike H; Kaganzi H; Ahimbisibwe GM; Businge GB; Kyambadde RC; Nakalega R
AIDS Res Ther; 2023 Mar; 20(1):18. PubMed ID: 36998004
[TBL] [Abstract][Full Text] [Related]
5. A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.
O'Connor JL; Gardner EM; Esser S; Mannheimer SB; Lifson AR; Telzak EE; Phillips AN;
HIV Med; 2016 Feb; 17(2):124-32. PubMed ID: 26186609
[TBL] [Abstract][Full Text] [Related]
6. Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya.
Maina EK; Mureithi H; Adan AA; Muriuki J; Lwembe RM; Bukusi EA
Int J Infect Dis; 2020 Aug; 97():151-158. PubMed ID: 32497804
[TBL] [Abstract][Full Text] [Related]
7. Determinants of viral load suppression failure among HIV adults on ARV attending health care facilities: a retrospective study in Tanga region, Tanzania.
Mboggo E; Mtisi E; Mushy SE; Mkawe S; Ngalesoni F; Muya A; Kilimba E; Kamugumya D; Mlay BS
BMC Infect Dis; 2024 Mar; 24(1):312. PubMed ID: 38486174
[TBL] [Abstract][Full Text] [Related]
8. Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.
Ladak F; Socias E; Nolan S; Dong H; Kerr T; Wood E; Montaner J; Milloy MJ
Antivir Ther; 2019; 24(1):19-25. PubMed ID: 30230474
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of intensive adherence counselling in achieving an undetectable viral load among people on antiretroviral therapy with low-level viraemia in Uganda.
Nanyeenya N; Nakanjako D; Makumbi F; Nakigozi G; Nalugoda F; Kigozi G; Nasuuna E; Kibira SPS; Nabadda S; Kiyaga C; Huzaifah M; Kiwanuka N
HIV Med; 2024 Feb; 25(2):245-253. PubMed ID: 37853605
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral therapy initiation within seven days of enrolment: outcomes and time to undetectable viral load among children at an urban HIV clinic in Uganda.
Ssebunya R; Wanyenze RK; Lukolyo H; Mutto M; Kisitu G; Amuge P; Maganda A; Kekitiinwa A
BMC Infect Dis; 2017 Jun; 17(1):439. PubMed ID: 28629459
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes after extended 12-month antiretroviral therapy prescriptions in a community-based differentiated HIV service delivery programme in South Africa: a retrospective cohort study.
Lewis L; Sookrajh Y; van der Molen J; Khubone T; Sosibo P; Maraj M; van Heerden R; Little F; Kassanjee R; Garrett N; Dorward J
J Int AIDS Soc; 2023 Sep; 26(9):e26164. PubMed ID: 37767825
[TBL] [Abstract][Full Text] [Related]
12. The association between low-level viraemia and subsequent viral non-suppression among people living with HIV/AIDS on antiretroviral therapy in Uganda.
Nanyeenya N; Chang LW; Kiwanuka N; Nasuuna E; Nakanjako D; Nakigozi G; Kibira SPS; Nabadda S; Kiyaga C; Makumbi F
PLoS One; 2023; 18(1):e0279479. PubMed ID: 36638086
[TBL] [Abstract][Full Text] [Related]
13. Unsuppressed viral load after intensive adherence counselling in rural eastern Uganda; a case of Kamuli district, Uganda.
Ndikabona G; Alege JB; Kirirabwa NS; Kimuli D
BMC Public Health; 2021 Dec; 21(1):2294. PubMed ID: 34922502
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral therapy programme outcomes at Senkatana antiretroviral therapy clinic, Lesotho: a four-year retrospective cohort study.
Kabuya M; Musekiwa A; Takuva S; Thabane L; Mbuagbaw L
Pan Afr Med J; 2023; 46():74. PubMed ID: 38282767
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with viral load non-suppression in people living with HIV on ART in Nigeria: cross-sectional analysis from 2017 to 2021.
Tomescu S; Crompton T; Adebayo J; Akpan F; Dauda DS; Allen Z; Ondura EO; Wose Kinge C; Chasela C; Pisa P
BMJ Open; 2023 May; 13(5):e065950. PubMed ID: 37169497
[TBL] [Abstract][Full Text] [Related]
16. Barriers to viral load suppression among adolescents living with HIV on anti-retroviral therapy: a retrospective study in Tanga, Tanzania.
Mushy SE; Mtisi E; Mkawe S; Mboggo E; Ndega J; Yahya-Malima KI; Kamugunya D; Kilimba ES; Mlay BS; Muya A; Ngalesoni F
AIDS Res Ther; 2024 May; 21(1):35. PubMed ID: 38778318
[TBL] [Abstract][Full Text] [Related]
17. Uptake of routine viral load testing among people living with HIV and its implementation challenges in Yangon region of Myanmar: a mixed-methods study.
Thinn KK; Thekkur P; Kyaw NTT; Aye NS; Zaw TM; Soan P; Hone S; Oo HN
BMJ Open; 2019 Dec; 9(12):e032678. PubMed ID: 31796489
[TBL] [Abstract][Full Text] [Related]
18. Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study.
O'Connor J; Smith C; Lampe FC; Johnson MA; Chadwick DR; Nelson M; Dunn D; Winston A; Post FA; Sabin C; Phillips AN;
Lancet HIV; 2017 Jul; 4(7):e295-e302. PubMed ID: 28479492
[TBL] [Abstract][Full Text] [Related]
19. [Viral load in HIV-infected children on high activity antiretroviral therapy].
Resino S; Bellón JM; León JA; Resino R; Muñoz-Fernández MA;
Med Clin (Barc); 2007 Jan; 128(2):49-51. PubMed ID: 17266901
[TBL] [Abstract][Full Text] [Related]
20. Effects of the COVID-19 pandemic on HIV service delivery and viral suppression: Findings from the SHARP program in Northern Nigeria.
Mugo C; Adedokun O; Alo OD; Ezeokafor N; Adeyemi S; Kpamor Z; Madueke L; James E; Adebajo SB; Semo BW
PLoS One; 2024; 19(4):e0300335. PubMed ID: 38564514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
